期刊文献+

绝经前乳腺癌患者新辅助化疗相关闭经的影响因素及临床意义探讨 被引量:5

Influence Factors of Neoadjuvant Chemotherapy-Related Amenorrhea in Premenopausal Breast Cancer Women and Its Clinical Significance
原文传递
导出
摘要 目的分析绝经前乳腺癌患者接受新辅助化疗后闭经的相关影响因素,了解新辅助化疗相关的闭经(NCRA)与新辅助化疗后肿瘤降期的关系。方法回顾性随访观察我院2006年3月至2011年3月期间224例绝经前乳腺癌患者接受新辅助化疗后月经状态的改变及新辅助化疗后彩超下乳房肿瘤的变化情况,分析新辅助化疗时患者年龄、化疗方案、肿瘤病理组织学特征(ER/PR和Her-2)、术后服用他莫昔芬(tamoxifen,TAM)与NCRA及其随后月经恢复的关系,以及新辅助化疗后肿瘤的变化与NCRA的关系。结果 224例患者中有166例(74.11%)患者出现NCRA,其中有15例停经但雌激素水平增高而行卵巢切除或接受戈舍瑞林治疗,余151例NCRA患者中有40例(26.49%)出现月经恢复。单因素及多因素分析结果显示,NCRA的发生及随后的月经恢复均与患者的年龄有关(P<0.001,P=0.001);不同化疗方案对NCRA的发生无明显影响(P>0.05),但是对NCRA后月经恢复有重要影响(P<0.001);肿瘤的ER/PR和Her-2表达和是否服用TAM对NCRA发生及其随后的月经恢复均无明显影响(P>0.05)。发生NCRA时的化疗周期数随患者年龄的增长而减少,与NCRA后月经的恢复无关(P>0.05)。NCRA的发生与新辅助化疗后肿瘤的降期无关(P>0.05)。结论大多数绝经前乳腺癌患者接受新辅助化疗后会出现闭经,年龄越大的患者越容易发生NCRA,而且发生NCRA时接受化疗的周期数更少;年龄和化疗方案都会影响NCRA后月经的恢复;NCRA的发生未影响新辅助化疗的近期疗效。 Objective To analyze the influence factors of amenorrhea in premenopausal breast cancer women treated with neoadjuvant chemotherapy and the relationship of neoadjuvant chemotherapy-related amenorrhea(NCRA) to down-staging of tumor.Methods Two hundred and twenty-four premenopausal breast cancer patients undergoing neoadjuvant chemotherapy from March 2006 to March 2011 in this hospital were investigated retrospectively.The effects of age,chemotherapy regiment,ER/PR status,Her-2 status,and tamoxifen(TAM)on NCRA and recovery of menstruation were assessed.The average age of the patients who had accepted different chemotherapy cycles when NCRA occurred was described,and the effect of different chemotherapy cycles on recovery of menstruation was evaluated.Tumor volume change was estimated to analysis the relation between NCRA and tumor response to chemotherapy.Results One hundred and sixty-six(74.11%)cases occurred NCRA,40(26.49%)cases returned to normal menstruation apart from 15 cases who had accepted oophorectomy or the luteinizing hormone-releasing hormone analog goserelin before menstrual status change.The results of univariate analysis and multivariate analysis indicated that the NCRA and menstruation recovery were both related to age at diagnosis(P0.001,P=0.001),and only menstruation recovery was related to chemotherapy regiments(P0.001).However,the NCRA and menstruation recovery were not related to ER/PR status,Her-2 status,and TAM(P0.05).Chemotherapy cycles when NCRA occurred decreased with the increase of age,and wasn’t associated with menstruation recovery(P 0.05).There was no correlation between NCRA and downstage of tumor after neoadjuvant chemotherapy(P0.05).Conclusions Amenorrhea resulted from neoadjuvant chemotherapy in most of breast cancer patients,which occurs more commonly in elder ones with less chemotherapy cycles.Quite a few patients resume menses after NCRA,which is associated with age and chemotherapy regiments.NCRA doesn’t influence tumor response to chemotherapy.
出处 《中国普外基础与临床杂志》 CAS 2013年第8期856-861,共6页 Chinese Journal of Bases and Clinics In General Surgery
关键词 新辅助化疗 乳腺肿瘤 闭经 周期性 Neoadjuvant chemotherapy Breast cancer Amenorrhea Periodicity
  • 相关文献

参考文献33

  • 1Beasley GM, Olson JA Jr. What's new in neoadjuvant therapy for breast cancer? [J]. Adv Surg, 2010, 44: 199-228.
  • 2Bear HD. Neoadjuvant chemotherapy for operable breast cancer: individualizing locoregional and systemic therapy [ J ]. Surg Oncol ClinNAm, 2010, 19(3): 607-626.
  • 3Ena G. Neoadjuvant therapy in breast cancer EJ]. Rev Med Brux, 2011, 32(4): 243-246.
  • 4Mauri D, Pavlidis N, Ioaunidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis CJ]. J Natl Cancer Inst, 2005, 97(3) : 188-194.
  • 5Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast cancer [J]. Ann Med, 2000, 32(1): 43-50.
  • 6Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer [J]. Crit Rev Oncol Hematol, 2010, 74(3): 175-192.
  • 7Walshe JM, Denduluri N, Swain SM. Amenorrhea in premeno- pausal women after adjuvant chemotherapy for breast cancer !J]. J Clin Oncol, 2006, 24(36): 5769-5779.
  • 8Del Mastro L, Venturini M, Sertoli MR, et al. Amenorrhea indu- ced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications [ J ]. Breast Cancer Res Treat, 1997, 43(2): 183-190.
  • 9KnobfMT. The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors [J]. Oncologist, 2006, 11(2): 96-110.
  • 10Hulvat MC, Jeruss JS. Maintaining fertility in young women with breast cancer [J]. Curr Treat Options Oncol, 2009, 10(5-6): 308-317.

同被引文献57

  • 1孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2008:371.
  • 2周岱翰,主编.临床中医肿瘤学[M].北京:人民卫生出版社.2005:185-195.
  • 3邵志敏,沈镇宙,徐兵河,主编.乳腺肿瘤学[M].上海:复旦大学出版社,2013: 24-25.
  • 4周易强.实用中医肿瘤学[M].北京:中国古籍出版社,2006:374-377.
  • 5郑篠萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002,5(1):212.
  • 6Manne SL,Siegel S,Kashy D,et al.Cancer-specific relationship awareness,relationship communication,and intimacy among couples coping with early stage breast cancer[J].J Soc Pers Relat,2014,31:314-334.
  • 7Printz C.More treatment options for women with hormone receptor-positive breast cancer:guideline update,studies lead to advances in care[J].Cancer,2014,120:2939-2940.
  • 8Han HS, RO J, Lee KS, et al. Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer [ J ]. Breast Cancer Res Treat, 2008, 115 ( 2 ) : 335-342.
  • 9Minisini AM, Menis J, Valent F, et al. Determinants of recoveryj from amenorrhea in premenopansal breast cancer patients receiving adjuvant chemotherapy in the taxane era [ J ]. Anticancer Drugs, 2009, 20 ( 6 ) : 503-507.
  • 10Tham YL, Sexton K, Weiss H, et al. The rates of chemotherapy- induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane [ J ]. Am J Clin Oncol, 2007, 30( 2 ) : 126-132.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部